GB201614593D0 - Novel use - Google Patents

Novel use

Info

Publication number
GB201614593D0
GB201614593D0 GBGB1614593.0A GB201614593A GB201614593D0 GB 201614593 D0 GB201614593 D0 GB 201614593D0 GB 201614593 A GB201614593 A GB 201614593A GB 201614593 D0 GB201614593 D0 GB 201614593D0
Authority
GB
United Kingdom
Prior art keywords
novel use
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1614593.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idogen AB
Original Assignee
Idogen AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idogen AB filed Critical Idogen AB
Priority to GBGB1614593.0A priority Critical patent/GB201614593D0/en
Publication of GB201614593D0 publication Critical patent/GB201614593D0/en
Priority to US16/328,539 priority patent/US20190201431A1/en
Priority to PCT/EP2017/071409 priority patent/WO2018037108A1/en
Priority to EP17758512.2A priority patent/EP3503897A1/en
Priority to PCT/EP2017/071404 priority patent/WO2018037103A1/en
Ceased legal-status Critical Current

Links

GBGB1614593.0A 2016-08-26 2016-08-26 Novel use Ceased GB201614593D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB1614593.0A GB201614593D0 (en) 2016-08-26 2016-08-26 Novel use
US16/328,539 US20190201431A1 (en) 2016-08-26 2017-08-25 Ex vivo methods of inducing ido expression in antigen presenting cells using a compound selected from the group consisting of azacytidine, and decitabine
PCT/EP2017/071409 WO2018037108A1 (en) 2016-08-26 2017-08-25 Ex vivo methods of inducing ido expression in antigen presenting cells using a compound selected from the group consisting of azacytidine, and decitabine
EP17758512.2A EP3503897A1 (en) 2016-08-26 2017-08-25 Ex vivo methods of inducing ido expression in antigen presenting cells using a compound selected from the group consisting of azacytidine, and decitabine
PCT/EP2017/071404 WO2018037103A1 (en) 2016-08-26 2017-08-25 Procainamide for treating immune disorders and for modulating ido expression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1614593.0A GB201614593D0 (en) 2016-08-26 2016-08-26 Novel use

Publications (1)

Publication Number Publication Date
GB201614593D0 true GB201614593D0 (en) 2016-10-12

Family

ID=57119838

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1614593.0A Ceased GB201614593D0 (en) 2016-08-26 2016-08-26 Novel use

Country Status (1)

Country Link
GB (1) GB201614593D0 (en)

Similar Documents

Publication Publication Date Title
GB201502152D0 (en) Novel use
GB201509326D0 (en) Novel use
GB2546834B (en) Jet-effect use
GB201718804D0 (en) Novel use
GB202004742D0 (en) Novel use
GB201412290D0 (en) Novel use
GB201522311D0 (en) Use
GB201522309D0 (en) Use
GB201521085D0 (en) Use
GB201417497D0 (en) Novel use
GB201613185D0 (en) Novel use
GB201518466D0 (en) Use
GB201510077D0 (en) Use
GB201620095D0 (en) Novel use
GB201621447D0 (en) Use
GB201614590D0 (en) Novel use
GB201417499D0 (en) Novel use
GB201709401D0 (en) Novel use
GB201709399D0 (en) Novel use
GB201614593D0 (en) Novel use
GB201614591D0 (en) Novel use
GB201614592D0 (en) Novel use
GB201708551D0 (en) Novel use
GB201708503D0 (en) Novel use
GB201620350D0 (en) Use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)